Pieris Pharmaceuticals Stock (NASDAQ: PIRS) stock price, news, charts, stock research, profile.
Open | $0.154 |
Close | $0.145 |
Volume / Avg. | 1.975M / 602.949K |
Day Range | 0.138 - 0.156 |
52 Wk Range | 0.136 - 1.010 |
Market Cap | $14.543M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 0.14% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pieris Pharmaceuticals (NASDAQ: PIRS) through any online brokerage.
Other companies in Pieris Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Eterna Therapeutics (NASDAQ:ERNA), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN) and Dominari Holdings (NASDAQ:DOMH).
The latest price target for Pieris Pharmaceuticals (NASDAQ: PIRS) was reported by Baird on Friday, March 13, 2020. The analyst firm set a price target for 5.00 expecting PIRS to rise to within 12 months (a possible 3301.36% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $0.147 last updated April 19, 2024 at 7:58 PM EDT.
There are no upcoming dividends for Pieris Pharmaceuticals.
Pieris Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
The stock split for PIRS was announced on Friday, April 19, 2024. The date this stock split will start trading, also known as the ex-date, will be on Tuesday, April 23, 2024.
Pieris Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.